GLP-1’s for Medical Weight Loss: What Patients Should Know

If you have been working toward a healthier weight and feel frustrated with your progress, you may be wondering whether GLP-1 medical weight loss could help. These prescription treatments can support weight management for eligible patients when combined with nutrition, physical activity, and medical follow-up. NIDDK

At Taylor Drive Facial Aesthetics, we want you to feel informed before choosing a treatment. Here is what to know about how these medications work, who may benefit, and what a thoughtful treatment plan involves.

What Are GLP-1 Medications?

GLP-1 stands for glucagon-like peptide-1, a hormone involved in appetite and blood sugar regulation. Medications that act on this pathway can reduce hunger and help you feel satisfied with less food. They also slow stomach emptying.

Two medications you may hear about are semaglutide and tirzepatide. Semaglutide targets GLP-1 receptors. Tirzepatide targets both GLP-1 and a second hormone pathway called GIP.

Specific products, including Wegovy (semaglutide) and Zepbound (tirzepatide), are FDA approved for weight management in eligible patients. The exact product matters: Wegovy has injectable and oral forms, while Zepbound is a weekly injection. Your provider can explain which options are appropriate for you. novo-pi.com

Who May Qualify for GLP-1 Medical Weight Loss?

For adults, common evaluation criteria include a body mass index (BMI) of 30 or higher, or 27 or higher with a weight-related health condition, such as high blood pressure or type 2 diabetes.

BMI is only part of the discussion. Your provider should also review your medical history, current medications, previous weight loss efforts, and health goals. Meeting a BMI threshold does not automatically mean a medication is the right choice. NIDDK

What Results Can Patients Expect?

Clinical trials show that these treatments can produce meaningful weight loss over time. In one major study, adults without diabetes taking semaglutide 2.4 mg weekly lost an average of about 15% of their starting weight over 68 weeks. In a separate study, adults without diabetes taking tirzepatide lost an average of about 15% to 21% over 72 weeks, depending on the dose. Both studies included lifestyle support. New England Journal of Medicine

These are study averages, and the trials were not a direct comparison with each other. Your results may differ based on the medication, dose, health history, and ability to continue treatment. Progress should be evaluated over months, with goals that reflect your individual health needs.

What Does a Treatment Plan Involve?

A GLP-1 medical weight loss plan should begin with a medical evaluation and clear instructions for the prescribed product. Treatment generally starts at a lower dose and increases gradually to help with tolerability. Follow the schedule your prescriber provides. novo-pi.com

Nutrition and movement remain essential. When appetite decreases, it is still important to get enough nutrients and protein. Resistance exercise, adapted to your ability, can help support muscle preservation during weight loss. Regular follow-up gives you a chance to discuss eating habits, hydration, side effects, and progress. PMC

What Side Effects and Precautions Should You Know?

Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. Some improve as treatment continues, but persistent symptoms deserve attention. More serious risks include pancreatitis, gallbladder problems, and kidney injury related to dehydration. pi.lilly.com

Contact your provider promptly for severe or persistent abdominal pain, repeated vomiting, or difficulty keeping fluids down. Trouble breathing or swelling of the face or throat requires emergency care. medlineplus.gov

Before starting, discuss these important considerations:

• Thyroid history: Semaglutide and tirzepatide should not be used with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2). Their boxed warnings reflect thyroid tumors seen in rodents; whether this occurs in humans is unknown. novo-pi.com
• Pregnancy and breastfeeding: These medicines should not be used for weight loss during pregnancy. Discuss pregnancy plans and breastfeeding before treatment. Semaglutide should be stopped at least two months before a planned pregnancy, with guidance from your prescriber. novo-pi.com
• Birth control: Tirzepatide can reduce the effectiveness of oral hormonal contraception. Its label advises a nonoral method or an added barrier method for four weeks after starting and four weeks after each dose increase. pi.lilly.com
• Other health conditions and medications: Share any history of pancreatitis, gallbladder disease, severe stomach-emptying problems, or diabetic eye disease. Also disclose insulin or diabetes medicines called sulfonylureas, which may require adjustment to reduce low blood sugar risk. novo-pi.com

Tell your surgical or anesthesia team if you use one of these medications before a procedure involving anesthesia or deep sedation. Your care team should give you individualized instructions. novo-pi.com

Why the Exact Medication Matters

Ask whether your prescription is an FDA-approved product or a compounded preparation. Compounded semaglutide and tirzepatide are not FDA approved and do not undergo the same premarket review for safety, effectiveness, and quality.

The FDA recommends compounded drugs only when a patient’s medical needs cannot be met by an approved medication. Make sure you understand the medication’s source, concentration, and dosing instructions before using it. FDA

Will You Need Long-Term Treatment?

Weight management often requires ongoing care. Some patients continue medication long term when it remains effective and well tolerated. Stopping can lead to weight regain, so discuss maintenance with your provider before changing treatment. NIDDK

Ask how follow-up visits, nutrition support, medication costs, and your long-term goals will fit into the plan. Knowing what to expect can help you make a decision that works for your health and daily life.

If you are curious about GLP-1 medical weight loss and want to start with a conversation about your health, goals, and treatment options, contact Taylor Drive Facial Aesthetics to schedule a consultation and learn more about our medical weight loss services.

This article is for educational purposes. Treatment eligibility and recommendations require an individualized medical evaluation.